SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-046588
Filing Date
2021-08-31
Accepted
2021-08-31 16:10:10
Documents
14
Period of Report
2021-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-8k_20210827.htm   iXBRL 8-K 53273
2 EX-99.1 tlis-ex991_6.htm EX-99.1 10603
3 GRAPHIC gnlh2bfwq05e000001.jpg GRAPHIC 16299
  Complete submission text file 0001564590-21-046588.txt   222002

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlis-20210827.xsd EX-101.SCH 5657
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlis-20210827_lab.xml EX-101.LAB 19325
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlis-20210827_pre.xml EX-101.PRE 11464
7 EXTRACTED XBRL INSTANCE DOCUMENT tlis-8k_20210827_htm.xml XML 3556
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 211227116
SIC: 3826 Laboratory Analytical Instruments